Pharmaceutical Composition for Prevention or Treatment of Post-Surgical Pain
Summary
EPO published patent application EP4084818A2 by Peptinov covering a pharmaceutical composition for preventing or treating post-surgical pain. The composition is classified under IPC codes A61K 38/17, A61K 38/20, and A61P 29/00, with inventors including Azoulai, Cassard, Salles, and Zagury. Designated states cover 31 European countries including major markets.
What changed
The EPO published patent application EP4084818A2 for a pharmaceutical composition developed by Peptinov intended for the prevention or treatment of post-surgical pain. The composition falls under therapeutic classifications related to proteins/peptides (A61K 38/17, A61K 38/20) and analgesics (A61P 29/00). The patent designates 31 European contracting states including Germany, France, Italy, Spain, and the UK.
This publication is informational regarding intellectual property rights and does not impose compliance obligations on pharmaceutical manufacturers or healthcare providers. Companies developing competing pain management therapies should review this patent for freedom-to-operate considerations. The patent grants Peptinov exclusive rights to the claimed composition in designated European states.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF POST-SURGICAL PAIN
Publication EP4084818A2 Kind: A2 Mar 25, 2026
Applicants
Peptinov
Inventors
AZOULAI, René, CASSARD, Xavier, SALLES, Jean-Pierre, ZAGURY, Jean-François
IPC Classifications
A61K 38/17 20060101AFI20220729BHEP A61K 38/20 20060101ALI20220729BHEP A61P 29/00 20060101ALI20220729BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Get daily alerts for EPO Patent Bulletin - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.